Research ArticleDrug Discovery and Translational Medicine
Lysophosphatidic acid receptor agonism: discovery of potent non-lipid benzofuran ethanolamine structures
Etienne Guillot, Jean-Christophe Le Bail, Pascal Paul, Valerie Fourgous, Pascale Briand, Michel Partiseti, Bruno Cornet, Philip Janiak and Christophe Philippo
Journal of Pharmacology and Experimental Therapeutics May 14, 2020, jpet.120.265454; DOI: https://doi.org/10.1124/jpet.120.265454
Etienne Guillot
Sanofi R&D
Jean-Christophe Le Bail
Sanofi R&D
Pascal Paul
Sanofi R&D
Valerie Fourgous
Sanofi R&D
Pascale Briand
Sanofi R&D
Michel Partiseti
Sanofi R&D
Bruno Cornet
Sanofi R&D
Philip Janiak
Sanofi R&D
Christophe Philippo
Sanofi R&D
Article Figures & Data
Additional Files
Data Supplement
- Supplemental Data -
1 supplemental figure, 4 tables.
- Supplemental Data -
In this issue
Research ArticleDrug Discovery and Translational Medicine
Lysophosphatidic acid receptor agonism: discovery of potent non-lipid benzofuran ethanolamine structures
Etienne Guillot, Jean-Christophe Le Bail, Pascal Paul, Valerie Fourgous, Pascale Briand, Michel Partiseti, Bruno Cornet, Philip Janiak and Christophe Philippo
Journal of Pharmacology and Experimental Therapeutics May 14, 2020, jpet.120.265454; DOI: https://doi.org/10.1124/jpet.120.265454
Research ArticleDrug Discovery and Translational Medicine
Lysophosphatidic acid receptor agonism: discovery of potent non-lipid benzofuran ethanolamine structures
Etienne Guillot, Jean-Christophe Le Bail, Pascal Paul, Valerie Fourgous, Pascale Briand, Michel Partiseti, Bruno Cornet, Philip Janiak and Christophe Philippo
Journal of Pharmacology and Experimental Therapeutics May 14, 2020, jpet.120.265454; DOI: https://doi.org/10.1124/jpet.120.265454
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement